-
Medical journals
- Career
Atypical course of Crohn’s disease with colonic involvement in a young patient
Authors: P. Vítek 1,2; I. Mikoviny Kajzrlíková 1; Přemysl Falt 2,3; P. Zonča 2,4; J. Platoš 1; M. Lukáš 5
Authors‘ workplace: Beskydské Gastrocentrum, Interní oddělení, Nemocnice ve Frýdku‑ Místku, p. o. 1; LF OU v Ostravě 2; Centrum péče o zažívací trakt, Vítkovická nemocnice a. s., Ostrava 3; Chirurgická klinika LF OU a FN Ostrava 4; Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F. a. s., Praha 5
Published in: Gastroent Hepatol 2016; 70(1): 61-64
Category: IBD: Case Report
doi: https://doi.org/10.14735/amgh201661Overview
A case of a young man treated by acute colectomy for severe colitis refractory to pharmacologic therapy is presented. Based on the presence of new atypical ulcers in his rectal stump, the disease was reclassified from ulcerative colitis to Crohn’s disease before subsequent reconstructive surgery. Ileorectal anastomosis was prefered to ileal pouch anal anastomosis.
Key words:
Crohn’s disease – colitis – colectomy
The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.
The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.Submitted:
22. 1. 2016Accepted:
8. 2. 2016
Sources
1. Dignass A, Eliakim R, Magro F et al. Second European evidence‑based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 2012; 6(10): 965 – 990. doi: 10.1016/ j.crohns.2012.09.003.
2. Turner D, Walsh CM, Steinhart AH et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta‑regression. Clin Gastroenterol Hepatol 2007; 5(1): 103 – 110.
3. Gibson DJ, Heetun ZS, Redmond CE et al.An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis. Clin Gastroenterol Hepatol 2015; 13(2): 330 – 335. doi: 10.1016/ j.cgh.2014.07.041.
4. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A): 5A – 36A.
5. Joossens S, Reinisch W, Vermeire S et al. The value of serologic markers in indeterminate colitis: a prospective follow‑up study. Gastroenterology 2002; 122(5): 1242 – 1247.
6. Windsor A, Michetti P, Bemelman W et al. The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy. Inflamm Bowel Dis 2013; 19(12): 2695 – 2703.
7. Holubar SD, Larson DW, Dozois EJ et al. Minimally invasive subtotal colectomy and ileal pouch ‑ anal anastomosis for fulminant ulcerative colitis: a reasonable approach? Dis Colon Rectum 2009; 52(2): 187 – 192. doi: 10.1007/ DCR.0b013e31819a5cc1.
8. Yu CS, Pemberton JH, Larson D. Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results. Dis Colon Rectum 2000; 43(11): 1487 – 1496.
Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery
Article was published inGastroenterology and Hepatology
2016 Issue 1-
All articles in this issue
- 21st Gastroforum, 2016
- The selection from international journals
- Cortiment® – first oral budesonide for the treatment of mild to middle active ulcerative colitis
- Anniversary year 2016...
- Medical art
- Guidelines for the administration of biological therapy in patients with inflammatory bowel diseases: third, updated edition
- Long-term functional outcomes and quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis
- Faecal microbial transplantation in inflammatory bowel disease
- Immunopathological complications of anti-TNF-α biological treatment
- Minimally invasive surgery in the treatment of inflammatory bowel disease – benefits, risks and perspectives
- Atypical course of Crohn’s disease with colonic involvement in a young patient
- Combination therapy of chronic hepatitis B
- New member of the editorial board
- Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study
- Gastroenterology and Hepatology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Cortiment® – first oral budesonide for the treatment of mild to middle active ulcerative colitis
- Faecal microbial transplantation in inflammatory bowel disease
- Long-term functional outcomes and quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis
- Immunopathological complications of anti-TNF-α biological treatment
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career